Theme: Why diabetes drugs might be an important potential line of treatment for Parkinson’s

Recorded at an in-person event.

The association between Type 2 diabetes and Parkinson’s risk and severity – Dr Alastair Noyce, Queen Mary University of London

Liraglutide in the treatment of Parkinson’s – Prof Michele Tagliati, Cedars Sinai

Exenatide for Parkinson’s – what’s next? – Dr Dilan Athauda, University College London

How helpful was this content?

/ 5. Vote count:

We are sorry that this content was not useful for you

Let us improve this content

Can you tell us how we can improve this content?